Search clinical trials for: nasal spray questionnaire

Total 11554 results

Dr. Ferrer BioPharma
Clinica Union Medica Del Norte, S.A.S., Santiago, República Dominicana

Active, not recruiting

Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis (ACCROS-R)

COVID-19 | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection | SARS CoV 2 Infection | COVID-19 Pandemic

Dominican Republic
Marinomed Biotech AG

Completed

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

COVID-19 | Common Cold | Respiratory Viral Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia | Corona Virus Disease

Austria
Washington University School of Medicine

Completed

Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis

Chronic Rhinosinusitis (Diagnosis) | Allergic Rhinosinusitis | Chronic Eosinophilic Rhinosinusitis

United States
Medical University Innsbruck

Withdrawn

ECT vs. Esketamine (ETES)

Major Depressive Disorder | Treatment Resistant Depression

Austria
Chulalongkorn University
Ramathibodi Hospital; Ministry of Health, Thailand; The Government Pharmaceutical... and other collaborators

Completed

Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail

SARS-CoV-2 Acute Respiratory Disease | SARS CoV 2 Infection

Thailand
Kerecis Ltd.

Completed

Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 (KONS-COVID19)

COVID-19

Iceland
University of Oxford
Stanford University; European Commission

Completed

FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV

Immunization

United Kingdom
VistaGen Therapeutics, Inc.

Completed

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge (Palisade-1)

Social Anxiety Disorder

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects

Depression

China
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Dry Eye Disease

Mexico
National Children's Hospital, Vietnam

Completed

Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children

Acute Respiratory Tract Infections

Vietnam
Oyster Point Pharma, Inc.

Completed

Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline

Healthy Subjects

United States
King's College London
Father Flanagan's Boys' Home

Completed

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy (OXYASP)

Antisocial Personality Disorder

United Kingdom
BlueWillow Biologics
Porton Biopharma Ltd.

Completed

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults (IN NE-rPA)

Anthrax

United States
Pocket Naloxone Corp

Completed

Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy Volunteers

Opioid Overdose

Canada
Nasus Pharma

Completed

A Single-Dose, Bioequivalence Study of FMXIN001 4 mg Microspheres Powder

Opioid Overdose

Canada
Kenneth Palmer
United States Department of Defense

Completed

PREVENT-COVID-19: A Q-Griffithsin Intranasal Spray

COVID-19 Prevention

United States
Sanofi

Completed

A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR) (NASANIF)

Rhinitis Allergic
Satsuma Pharmaceuticals, Inc.

Completed

A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects

Migraine | Migraine Without Aura | Migraine With Aura

United States
Pari Pharma GmbH

Completed

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis

Rhinosinusitis

Germany
Pari Pharma GmbH

Completed

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi

Rhinosinusitis | Chronic Polyposis

Germany
Community and Patient Preference Research Pty Ltd
Seqirus Limited; Glenmark Pharmaceuticals

Withdrawn

Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes

Allergic Rhinitis

Australia
Bayer

Completed

Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis

Allergic Rhinitis

Canada
University Children's Hospital Basel
Swiss National Science Foundation

Completed

Breath Metabolomics of Placebo Effects, a Pilot Study (BMPE)

Analgesia

Switzerland
Thomas Jefferson University

Completed

A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine

Migraine

United States
Cellular Sciences, inc.
Missouri State University; Dynamic DNA Labs; Trinity Health Care; Family First...

Completed

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

Long COVID

United States
Oyster Point Pharma, Inc.

Completed

Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study)

Dry Eye Disease

United States
MEDA Pharma GmbH & Co. KG

Completed

MP-AzeFlu Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
MEDA Pharma GmbH & Co. KG

Completed

DYmista NAsal Spray in CHInese Patients (DYNAS-CHI)

Allergic Rhinitis

China
Organon and Co

Withdrawn

Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED)

Nasal Obstruction | Adenoidectomy | Adenoids Hypertrophy
Organon and Co

Completed

Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)

Acute Rhinosinusitis
Organon and Co

Completed

Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)

Allergic Rhinitis
Organon and Co

Completed

Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)

Acute Rhinosinusitis
Organon and Co

Completed

Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)

Nasal Polyps
Organon and Co

Completed

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)

Allergic Rhinitis
Organon and Co

Completed

Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)

Rhinitis, Allergic, Perennial
Organon and Co

Completed

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)

Allergic Rhinitis
Organon and Co

Completed

A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)

Rhinitis, Allergic, Perennial
Organon and Co

Completed

This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)

Rhinitis, Allergic
Organon and Co

Completed

A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)

Perennial Allergic Rhinitis
Organon and Co

Completed

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)

Seasonal Allergic Rhinitis
Irkutsk Scientific Center of the Siberian Branch...
Irkutsk State Medical University

Completed

COVID-19 Methylene Blue Antiviral Treatment (COMBAT)

Covid19

Russian Federation
Organon and Co

Completed

Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)

Rhinitis, Allergic, Seasonal
Organon and Co

Completed

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)

Seasonal Allergic Rhinitis
Organon and Co

Completed

Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)

Allergic Rhinitis
Organon and Co
Integrated Therapeutics Group

Completed

Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)

Seasonal Allergic Rhinitis
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Prolytic GmbH; pharm-analyt GmbH

Completed

Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays

Allergic Rhinitis

Germany

3

Subscribe